About 3H Health Investment
3H Health Investment is a private equity firm founded in 2016. It is primarily based in Hong Kong, China. In the last 12 months, it has participated in 2 funding rounds.
A lot of funds co-invest with 3H Health Investment, with names like Hillhouse sharing a substantial percentage of its portfolio.
3H Health Investment has a team of 10 people, including 5 partners.
Key Metrics
3H Health Investment's Portfolio
They have invested in a total of 24 companies. Their most recent investment was in Vast3D (Series B round) on Sep 01, 2026. Here is the most recent investment by 3H Health Investment:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Sep 01, 2026 | Series B | 4091 | ||
Feb 05, 2026 | Series D | 1779 | ||
Jan 09, 2025 | Series A | 6462 | and 4 others | |
Dec 11, 2024 | Series C | 1634 |
Here is the portfolio snapshot of 3H Health Investment:
Investments by Year
The maximum number of investments were made in 2021
Team profile of 3H Health Investment
3H Health Investment has a team of 10 members including 5 Partners and 4 Principals located in China. 3H Health Investment's team does not sit on the board of any company as of now.Here is a list of all team members in 3H Health Investment:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Hong Kong | - | - | |
Partner | - | - | - | |
Partner | China | - | - | |
Partner | China | - | - | |
Partner | Hong Kong | - | - | |
Principal | Shanghai | - | - | |
Principal | Hong Kong | - | - | |
Principal | China | - | - | |
Principal | Hong Kong | - | - | |
Analyst | China | - | - |
Co-investors of 3H Health Investment
Over the past 10 years, 81 investors have co-invested in 3H Health Investment's portfolio companies.
- Top Co-investors of 3H Health Investment: 81 investors entered a company along with 3H Health Investment. These include investors like Hillhouse (4 companies).
3H Health Investment News
•
Timberlyne Therapeutics Raises $180M in Series A FundingFinSMEs•Jan 10, 2025•Timberlyne, Abingworth, Bain Capital Life Sciences, Venrock and 6 others
•
Angitia raises $120M series C to fund trio of musculoskeletal trialsFierce Biotech•Dec 11, 2024•Angitia, Janus Henderson Investors, Orbimed, 3H Health Investment and 2 others
•
Angitia Biopharmaceuticals Raises $120M in Series C FundingFinSMEs•Dec 11, 2024•Angitia, Bain Capital Life Sciences, Janus Henderson Investors, Orbimed and 4 others
•
Atlas doubles down on ‘disciplined’ biotech investing with latest fundraiseBioPharmaDive•Dec 05, 2024•Atlas Venture, Arch Venture Partners, Flagship Pioneering, Bain Capital Life Sciences and 6 others
•
•
•
•
•
•
